11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Verona Pharma Plc (VRNA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 34,690 | $2,202,468 | 0.97% | |
| 2. | BIT Capital GmbH Jan Beckers | 5,407 | $343,290 | -84% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 20,000 | Director | 940,003 | 2024-11-18 | Filing | |
| $4.80 | 39,360 | Director | 920,003 | 2024-11-06 | Filing | |
| $4.74 | 41,880 | Director | 41,880 | 2024-11-06 | Filing | |
| $2.87 | 36,000 | Director | 880,643 | 2024-08-12 | Filing | |
| $1.84 | 33,736 | Director | 144,800 | 2023-11-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.82 | 114,984 | Officer | 2,546,472 | 2025-05-06 | Filing | |
| $8.95 | 21,864 | Officer | 2,661,456 | 2025-05-01 | Filing | |
| $8.95 | 27,336 | Officer | 2,633,320 | 2025-05-01 | Filing | |
| $9.09 | 400,000 | Officer | 13,078,992 | 2025-05-02 | Filing | |
| $8.95 | 78,736 | Officer | 13,478,992 | 2025-05-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,267,761 | $80,490,146 | 0.17% | |
| 2. | 1,261,153 | $80,070,604 | 0.06% | |
| 3. | 1,041,408 | $66,118,994 | 0.01% | |
| 4. | 823,012 | $52,253,032 | 3.07% | |
| 5. | 703,063 | $44,582,935 | 0.05% |
News See All
What Makes Verona Pharma plc (VRNA) a Good Investment?
Buckley Capital Advisors, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Verona Pharma plc (NASDAQ:VRNA) Q1 2025 Earnings Call Transcript
Operator: Welcome to Verona Pharma plc's First Quarter 2025 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks to Buy According to Billionaires
US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets.
Jim Cramer Focused On These 9 Stocks Recently
Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions revolving around the Federal Reserve, interest rates, and the President's trade...
10 Best Performing Growth Stocks in 2025
Heavy AI investments and the tariffs uncertainty have been putting pressure on the technology and growth sector.
Verona Pharma plc (VRNA): A Bull Case Theory
We came across a bullish thesis on Verona Pharma plc (VRNA) on Value Investing Subreddit Page by loud_keyb. In this article, we will summarize the bulls’ thesis on VRNA.
Verona Pharma plc (NASDAQ:VRNA) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Verona Pharma fourth quarter and full year 2024 financial results and conference call. At this time, all lines are in listen-only mode.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...
Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Billionaire Hedge Funds
